Drug Profile
Methylphenidate - UCB
Alternative Names: Equasym; Metadate; Metadate CD; Metadate ER; Methylphenidate MR racemate; SPD 544Latest Information Update: 26 Nov 2021
Price :
$50
*
At a glance
- Originator UCB
- Developer Takeda; UCB
- Class Behavioural disorder therapies; Neuroprotectants; Nootropics; Phenylacetates; Piperidines; Sleep disorder therapies; Small molecules
- Mechanism of Action Adrenergic receptor modulators; Dopamine release stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Attention-deficit hyperactivity disorder